19-41327262-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000598758.5(TGFB1):​n.302+4866A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.855 in 152,130 control chromosomes in the GnomAD database, including 56,079 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.86 ( 56079 hom., cov: 31)

Consequence

TGFB1
ENST00000598758.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.248

Publications

29 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.957 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFB1ENST00000598758.5 linkn.302+4866A>G intron_variant Intron 2 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.855
AC:
129993
AN:
152012
Hom.:
56016
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.965
Gnomad AMI
AF:
0.889
Gnomad AMR
AF:
0.842
Gnomad ASJ
AF:
0.754
Gnomad EAS
AF:
0.856
Gnomad SAS
AF:
0.896
Gnomad FIN
AF:
0.816
Gnomad MID
AF:
0.725
Gnomad NFE
AF:
0.800
Gnomad OTH
AF:
0.835
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.855
AC:
130118
AN:
152130
Hom.:
56079
Cov.:
31
AF XY:
0.855
AC XY:
63593
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.965
AC:
40072
AN:
41534
American (AMR)
AF:
0.842
AC:
12865
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.754
AC:
2617
AN:
3470
East Asian (EAS)
AF:
0.856
AC:
4416
AN:
5158
South Asian (SAS)
AF:
0.896
AC:
4318
AN:
4820
European-Finnish (FIN)
AF:
0.816
AC:
8627
AN:
10566
Middle Eastern (MID)
AF:
0.714
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
0.800
AC:
54411
AN:
67984
Other (OTH)
AF:
0.837
AC:
1771
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
936
1872
2808
3744
4680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
886
1772
2658
3544
4430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.807
Hom.:
96524
Bravo
AF:
0.860
Asia WGS
AF:
0.900
AC:
3127
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
3.1
DANN
Benign
0.62
PhyloP100
-0.25
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10417924; hg19: chr19-41833167; API